1666 Stock Overview
Manufactures and sells Chinese medicine products in Mainland China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.83 |
| 52 Week High | HK$7.03 |
| 52 Week Low | HK$4.63 |
| Beta | 1.04 |
| 11 Month Change | -4.17% |
| 3 Month Change | -7.29% |
| 1 Year Change | -17.44% |
| 33 Year Change | -18.82% |
| 5 Year Change | -35.69% |
| Change since IPO | 573.96% |
Recent News & Updates
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In Tong Ren Tang Technologies' (HKG:1666) Earnings
Sep 06
Investor Optimism Abounds Tong Ren Tang Technologies Co. Ltd. (HKG:1666) But Growth Is Lacking
May 25Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly
Mar 28Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price
Feb 01With EPS Growth And More, Tong Ren Tang Technologies (HKG:1666) Makes An Interesting Case
Dec 20Tong Ren Tang Technologies (HKG:1666) Could Easily Take On More Debt
Oct 12Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 38% Discount?
Sep 19Do Tong Ren Tang Technologies' (HKG:1666) Earnings Warrant Your Attention?
Apr 13Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?
Dec 01Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly
Aug 30Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 43% Discount?
Jul 11Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly
Apr 21We Think Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt With Ease
Dec 22Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly
Sep 06Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?
Apr 25Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Intrinsic Value Is Potentially 22% Below Its Share Price
Mar 20Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) A Great Dividend Stock?
Feb 21Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Feb 03
If You Had Bought Tong Ren Tang Technologies' (HKG:1666) Shares Three Years Ago You Would Be Down 61%
Jan 16What Can We Learn About Tong Ren Tang Technologies' (HKG:1666) CEO Compensation?
Dec 28Does This Valuation Of Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Imply Investors Are Overpaying?
Dec 15What Kind Of Shareholders Hold The Majority In Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Shares?
Dec 02Shareholder Returns
| 1666 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -0.6% | 2.8% | 3.0% |
| 1Y | -17.4% | 8.4% | -0.9% |
Return vs Industry: 1666 underperformed the Hong Kong Pharmaceuticals industry which returned 8.4% over the past year.
Return vs Market: 1666 underperformed the Hong Kong Market which returned -0.9% over the past year.
Price Volatility
| 1666 volatility | |
|---|---|
| 1666 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in HK Market | 13.2% |
| 10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 1666 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1666's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 4,005 | Jia Fu Chen | www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
| 1666 fundamental statistics | |
|---|---|
| Market cap | HK$6.19b |
| Earnings (TTM) | HK$717.99m |
| Revenue (TTM) | HK$7.59b |
8.6x
P/E Ratio0.8x
P/S RatioIs 1666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1666 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.88b |
| Cost of Revenue | CN¥4.06b |
| Gross Profit | CN¥2.82b |
| Other Expenses | CN¥2.17b |
| Earnings | CN¥650.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 40.97% |
| Net Profit Margin | 9.46% |
| Debt/Equity Ratio | 22.7% |
How did 1666 perform over the long term?
See historical performance and comparison